Exercise With Blood Flow Restriction in Knee Osteoarthritis (BFROA)

May 23, 2022 updated by: José Casaña Granell, University of Valencia

Neuromuscular Responses, Pain Intensity and Perceived Exertion of Resistance Exercise With Blood Flow Restriction in Patients With Severe Knee Osteoarthritis

The purpose of this study is to evaluate the neuromuscular responses, pain intensity and rate of perceived exertion in patients with severe knee osteoarthritis in a preoperative setting with low-load resistance training with blood flow restriction at different levels of arterial occlusion pressure.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valencia, Spain, 46010
        • Clinic Universitary Hospital of Valencia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • men and women above 55 years old.
  • diagnosed with severe knee osteoarthritis.
  • scheduled for unilateral TKA surgery in a local hospital during 2021- 2022.

Exclusion Criteria:

  • pain in the contralateral limb (maximum pain, ≥80 of 100 mm on a VAS during daily activities).
  • another hip or knee joint replacement in the previous year.
  • any medical condition in which exercise was contraindicated.
  • participated in exercise programs (>2 days/week, training at intensities of 10-15RM) in the 6 months prior to the study.
  • history of stroke, brain surgery, major depression, or any self-perceived cognitive alterations that could affect the performance of dual tasks.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Placebo
Knee extensions with 30% 1RM and no occlusion pressure.
4 sets (30, 15, 15, 15 reps).
EXPERIMENTAL: BFR at 40% AOP
Knee extensions with 30% 1RM and BFR at 40% AOP.
4 sets (30, 15, 15, 15 reps).
EXPERIMENTAL: BFR at 80% AOP
Knee extensions with 30% 1RM and BFR at 80% AOP.
4 sets (30, 15, 15, 15 reps).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported pain intensity (Visual Analogue Scale (VAS) Scale 0-10)
Time Frame: Pre exercise, immediate post set, immediate post session, and 10 minutes after session.
Change from baseline to the end of the session, and the change between the treatment group and the placebo group.
Pre exercise, immediate post set, immediate post session, and 10 minutes after session.
Pressure pain thresholds
Time Frame: Pre exercise, immediate post session, and 10 minutes after session.
Change from baseline to the end of the session, and the change between the treatment group and the placebo group.
Pre exercise, immediate post session, and 10 minutes after session.
HDsEMG
Time Frame: During each experimental session and during each exercise condition.
Change between baseline and exercise, and the change between the treatment group and the placebo group.
During each experimental session and during each exercise condition.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tampa Scale of Kinesiophobia (TSK 11)
Time Frame: Pre session.
Its score range is 11-44, with higher scores reflecting worse condition.
Pre session.
Pain Catastrophizing Scale (PCS)
Time Frame: Pre session.
People are asked to indicate the degree to which they have certain thoughts and feelings when they are experiencing pain using the 0 (not at all) to 4 (all the time) scale. A total score is yielded (ranging from 0-52), along with three subscale scores assessing rumination, magnification and helplessness, with higher scores reflecting worse condition.
Pre session.
Chronic Pain Self-Efficacy Scale (CPSS)
Time Frame: Pre session.
The Chronic Pain Self-Efficacy Scale (CPSS) is designed to measure chronic pain patients' perceived self-efficacy to cope with the consequences of chronic pain. The CPSS measures three domains of pain self-efficacy: pain management, physical functioning, and coping with symptoms. A total score is yielded (ranging from 220-2200), with higher scores reflecting a better condition.
Pre session.
WOMAC questionaire for patients with hip or knee osteoarthritis.
Time Frame: Pre session.
The WOMAC is a disease-specific self-administered questionnaire for patients with hip or knee osteoarthritis. It has a multidimensional scale made up of 24 items grouped into three dimensions: pain (5 items), stiffness (2 items) and physical function (17 items). For each item, it uses a Likert scale with five response levels, representing different degrees of intensity (none, mild, moderate, severe or extreme) that are scored from 0 to 4. The final score for the WOMAC is determined by adding the aggregate scores for pain, stiffness and function. The higher the score, the worse the patient's condition.
Pre session.
Heart Rate
Time Frame: Pre exercise, immediate post set, immediate post session, and 10 minutes after session.
Change from baseline to the end of the session, and the change between the treatment group and the placebo group.
Pre exercise, immediate post set, immediate post session, and 10 minutes after session.
Rating of perceived exertion (RPE) based on Borg's CR10 scale
Time Frame: Immediate post exercise.
The Borg CR10 scale is a tool for measuring an individual's effort and exertion during physical work. It is a very simple numerical list from 0 (no exertion at all) to 10 (maximal intensity of activity). Participants are asked to rate their exertion on the scale during the activity, combining all sensations and feelings of physical stress and fatigue. They are told to disregard any one factor such as leg pain or shortness of breath but to try to focus on the whole feeling of exertion.
Immediate post exercise.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 21, 2022

Primary Completion (ACTUAL)

May 13, 2022

Study Completion (ACTUAL)

May 20, 2022

Study Registration Dates

First Submitted

February 15, 2022

First Submitted That Met QC Criteria

March 5, 2022

First Posted (ACTUAL)

March 11, 2022

Study Record Updates

Last Update Posted (ACTUAL)

May 24, 2022

Last Update Submitted That Met QC Criteria

May 23, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on BFR resistance exercise

Subscribe